Literature DB >> 5303665

A controlled field trial of the effectiveness of various doses of cholera El Tor vaccine in the Philippines.

.   

Abstract

A controlled field trial of the effectiveness of various doses of cholera El Tor vaccine was organized in Negros Occidental Province, an area of endemic cholera in the Philippines, in 1966 and 1967, on 359 600 volunteers. The population was divided, by random allocation, into four equal groups, and vaccines were administered as follows: Group A, one dose of 1 ml of vaccine containing 8 x 10(9) organisms/ml; Group B, 2 doses (1 ml each) of the same cholera vaccine; Group C, one dose of vaccine containing 16 x 10(9) organisms/ml; and Group D, 2 doses of typhoid vaccine as a control.During the follow-up period of 6 months, a total of 95 bacteriologically proven cases were observed. The rates of protection were 53%, 55% and 58% respectively, which were statistically significant. Maximum protection was observed in Group C, but the difference between the degree of protection in the various groups was not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5303665      PMCID: PMC2554519     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  FIELD TRIAL OF CHOLERA VACCINE IN RURAL EAST PAKISTAN. FIRST YEAR OF OBSERVATION.

Authors:  R O OSEASOHN; A S BENENSON; M FAHIMUDDIN
Journal:  Lancet       Date:  1965-02-27       Impact factor: 79.321

  1 in total
  2 in total

Review 1.  Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Authors:  Patricia M Graves; Jonathan J Deeks; Vittorio Demicheli; Tom Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

2.  Scalable production and immunogenicity of a cholera conjugate vaccine.

Authors:  Suhi Jeon; Meagan Kelly; Jeesun Yun; Byungman Lee; Minchul Park; Yoonhee Whang; Chankyu Lee; Yuan-Di Halvorsen; Smriti Verma; Richelle C Charles; Jason B Harris; Stephen B Calderwood; Daniel T Leung; Taufiqur R Bhuiyan; Firdausi Qadri; Mohammad Kamruzzaman; Somyoung Cho; Willie F Vann; Peng Xu; Pavol Kováč; Ravi Ganapathy; Julia Lynch; Edward T Ryan
Journal:  Vaccine       Date:  2021-10-27       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.